| Value | ₹2,140 Cr |
|---|
BSE filing, NSE: INSECTICID. Summary written from the filing by ALFA Finder's alert engine.
Insecticides (India) Ltd: key numbers
- Share price
- ₹512.45
- Market cap
- ₹1,491 Cr
- Revenue (annual)
- ₹2,140 Cr
- Net profit (annual)
- ₹139.4 Cr
- P/E (TTM)
- 11.9×Sector 34.1×
- Promoter holding
- 72.30%+0.00% QoQ
- FII holding
- 4.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Insecticides (India) Ltd
All →Insecticides (India) Board Meeting Date
Insecticides (India) will hold a board meeting on November 5, 2026 to consider an interim dividend for FY 2026-27. Record date is fixed as November 12, 2026.
Insecticides (India) Other Announcement
Insecticides (India) Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory disclosure.
Insecticides (India) Credit Rating
CRISIL Ratings has reaffirmed the Long-Term and Short-Term credit ratings of Insecticides (India) Limited. There is no change in the ratings assigned to the company.
Insecticides (India) Board Meeting Date
Insecticides (India) Ltd will hold a board meeting on November 5, 2026, to approve its Q2 financial results. The trading window remains closed from October 1 until the results declaration.
Insecticides (India) Annual General Meeting
Insecticides (India) Ltd conducted its 29th Annual General Meeting on August 12, 2026. Shareholders deliberated on seven agenda items, with voting results to be disclosed later.
Insecticides (India) Earnings Call Transcript: Key Takeaways
Q1FY27 was impacted by delayed monsoons, shifting demand later. Despite revenue decline, gross margins improved due to premiumization and inventory management, though EBITDA softened on negative operating leverage.
- Call
- Guides 100% growth
Other results update announcements
All →Aatmaj Healthcare Results Update
Aatmaj Healthcare reported H1 FY27 revenue of Rs. 16.96 crore and EBITDA of Rs. 2.04 crore. The company targets 80% revenue growth for FY27.
RPG Life Sciences Results Update
RPG Life Sciences reported Q2 FY27 revenue of ₹211.6 crore, growing 16.5%, and adjusted EBITDA of ₹50.1 crore. The API business integration continues to progress.
Praruh Technologies Results Update
Praruh Technologies reported strong H1 FY27 growth, with revenue rising 378% YoY to ₹84.06 Crore and PAT increasing 733% to ₹8.18 Crore.
CARE Ratings Results Update
CARE Ratings reported strong Q2 and H1 FY27 operating income and profit growth. The board also declared an interim dividend of Rs 10 per share.
EPACK Durables Results Update
EPACK Durable reported record first-half revenue and strong Q2 FY27 growth. The board also approved exiting its EPAVO joint venture stake.
3i Infotech Results Update
3i Infotech reported Q2FY27 revenue of Rs.182.0 crore, up 4.1% year-on-year. Quarterly PAT stood at Rs.6.7 crore and 25 new client wins were added.